MicroRNAs in DNA damage response and BCR signaling in malignant B cells.

ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Michal JEŽ, Nikola TOM, Jitka MALČÍKOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER, Jaroslav KOČA, M. ARIGONI, F. RICARDO, R. CALOGERO, Šárka POSPÍŠILOVÁ and Marek MRÁZ. MicroRNAs in DNA damage response and BCR signaling in malignant B cells. In MicroRNAs and Noncoding RNAs in Cancer. 2015.

Basic information

• Original name: MicroRNAs in DNA damage response and BCR signaling in malignant B cells.
• Authors: ČERNÁ, Kateřina, Jan OPPELT, Lenka RADOVÁ, Kateřina MUSILOVÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, Michal JEŽ, Nikola TOM, Jitka MALČÍKOVÁ, Boris TICHÝ, Yvona BRYCHTOVÁ, Michael DOUBEK, Martin TRBUŠEK, Jiří MAYER, Jaroslav KOČA, M. ARIGONI, F. RICARDO, R. CALOGERO, Šárka POSPÍŠILOVÁ and Marek MRÁZ.
• Edition: MicroRNAs and Noncoding RNAs in Cancer, 2015.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 30200 3.2 Clinical medicine
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology
• Tags: International impact, Reviewed

Links

• ED1.1.00/02.0068, research and development project: Name: CEITEC - central european institute of technology
• MUNI/A/1180/2014, interní kód MU: Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit II (Acronym: VýDiTeHeMa II)

Investor: Masaryk University, Category A

• NT11218, research and development project: Name: Funkční a strukturní změny microRNA u lymfoproliferativních malignit a jejich vliv na prognózu onemocnění a predikci léčebné odpovědi
• 306242, interní kód MU: Name: NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)

Investor: European Union, Cooperation